Physician profile
John P Long
NPI 1568460541
$662.49
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $212 · 2020: $183 · 2021: $24.17 · 2022: $244.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $163.17 | 2022 | |
| Boston Scientific Corporation | $160.49 | 2019-2022 | |
| Astellas Pharma US INC | $112.33 | 2019-2020 | |
| Tolmar Pharmaceuticals, INC. | $65.21 | 2019-2021 | |
| Abbvie INC. | $49.20 | 2019-2020 | |
| Coloplast Corp | $45.87 | 2019-2020 | |
| Pfizer INC. | $31.69 | 2020 | |
| 180 Medical, INC. | $19.07 | 2019 | |
| Dentsply Ih INC. | $15.46 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Long listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.